A
Akura Medical
Innovative thrombectomy platform for efficient large volume clot removal with minimal guesswork
About Akura Medical
Akura Medical, a Shifamed Portfolio Company, specializes in developing advanced mechanical thrombectomy solutions aimed at efficiently removing large volume, mixed morphology clots. The company operates in the medical device market, focusing on vascular and pulmonary embolism treatments. Akura Medical primarily serves healthcare providers, including hospitals and specialized clinics, that require high-performance tools for clot removal procedures. The business model revolves around the research, development, and eventual commercialization of its proprietary thrombectomy platform. Revenue is generated through the sale of these medical devices once they receive regulatory approval, such as FDA clearance. Currently, the company is in the research and development phase and has secured $35M in Series B financing to expand clinical programs and scale manufacturing.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Dec 2025 | $53M | $212M | Qatar Investment Authority | ↗ |
| SERIES BOther financing | Oct 2023 | $35M | $140M | Shifamed Angels · PA MedTech VC Fund · Lilly Asia Ventures · Unorthodox ventures | ↗ |
Growth signals
Latest recorded traffic for Akura Medical is 2.7K monthly website visits, up 28.6% over the last three months. Akura Medical's team grew 184.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Akura Medical in the Los Gatos ecosystem
The Akura Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Cormorant Asset Management
The Capital Partnership
Shifamed Angels
MedTech VP- PFPA MedTech VC Fund
Lilly Asia Ventures
Unorthodox ventures
AMED Ventures
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Akura Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Akura Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










